References
- Feuillard J, Jacob MC, Valensi F, Maynadie M, Gressin R, Chaperot L, et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood 2002;99:1556-63. https://doi.org/10.1182/blood.V99.5.1556
- Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937-51. https://doi.org/10.1182/blood-2009-03-209262
- Burg G, Kempf W, Cozzio A, Feit J, Willemze R, E SJ, et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 2005;32:647-74. https://doi.org/10.1111/j.0303-6987.2005.00495.x
- Cota C, Vale E, Viana I, Requena L, Ferrara G, Anemona L, et al. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients. Am J Surg Pathol 2010;34:75-87. https://doi.org/10.1097/PAS.0b013e3181c5e26b
- Leroux D, Mugneret F, Callanan M, Radford-Weiss I, Dastugue N, Feuillard J, et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique. Blood 2002;99:4154-9. https://doi.org/10.1182/blood.V99.11.4154
- Lucioni M, Novara F, Fiandrino G, Riboni R, Fanoni D, Arra M, et al. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood 2011;118:4591-4. https://doi.org/10.1182/blood-2011-03-337501
- Wiesner T, Obenauf AC, Cota C, Fried I, Speicher MR, Cerroni L. Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms. J Invest Dermatol 2010;130:1152-7. https://doi.org/10.1038/jid.2009.369
- Toya T, Nishimoto N, Koya J, Nakagawa M, Nakamura F, Kandabashi K, et al. The first case of blastic plasmacytoid dendritic cell neoplasm with MLL-ENL rearrangement. Leuk Res 2012;36:117-8. https://doi.org/10.1016/j.leukres.2011.07.029
- Wang H, Cao J, Hong X. Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review. Acta Haematol 2012;127:124-7. https://doi.org/10.1159/000334703
- Bekkenk MW, Jansen PM, Meijer CJ, Willemze R. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 2004;15:1097-108. https://doi.org/10.1093/annonc/mdh268
- Rauh MJ, Rahman F, Good D, Silverman J, Brennan MK, Dimov N, et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review. Leuk Res 2012;36:81-6. https://doi.org/10.1016/j.leukres.2011.07.033
- Ham JC, Janssen JJ, Boers JE, Kluin PM, Verdonck LF. Allogeneic stem-cell transplantation for blastic plasmacytoid dendritic cell neoplasm. J Clin Oncol 2012;30:e102-3. https://doi.org/10.1200/JCO.2011.35.8143
Cited by
- Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single‐center experience and literature review vol.33, pp.4, 2014, https://doi.org/10.1002/hon.2147
- NK-Cell Lymphoblastic Leukemia/Lymphoma (Literature Review and Authors' Experience) vol.9, pp.2, 2014, https://doi.org/10.21320/2500-2139-2016-9-2-208-217
- Simultaneous deletion of 3′ETV6 and 5′EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review vol.9, pp.None, 2014, https://doi.org/10.1186/s13039-016-0232-1